| Screening | Baseline T0 | Follow-up T1 (3 month) | Follow-up T2 (18 month) |
---|---|---|---|---|
IDS-SR | x | x | x | x |
SCID-I interview | Â | Â | x | Â |
 incl. Life chart method | x |  |  | x |
DART | x | Â | Â | Â |
ERQ | Â | x | x | Â |
LEIDS-RR | Â | x | x | Â |
LARSS | Â | x | x | Â |
RPA | Â | x | x | Â |
BVAQ | Â | x | x | Â |
CTQ | Â | x | Â | Â |
NEO-FFI | Â | x | x | Â |
DAS | Â | x | x | x |
PANAS | Â | x | x | Â |
DDOPS | Â | x | x | Â |
ARDPEI with PDR | Â | x | x | Â |
IAT with PDR | Â | x | x | Â |
Emotional Reasoning Task | Â | x | x | Â |
WAIS-IV subtests | Â | x | x | Â |
fMRI ERT with PDR + SCR + HRV + RC |  | x | x |  |
fMRI VWMT with PDR + SCR + HRV + RC |  | x | x |  |
fMRI Resting State with SCR + HRV + RC |  | x | x |  |
MRI T1 with SCR + HRV + RC |  | x | x |  |
MRI arterial spin labelling with HRV + RC |  | x | x |  |
HAQ-II | Â | Â | x | Â |
Brugha list | Â | Â | x | x |